NL7408580A - Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier - Google Patents

Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier

Info

Publication number
NL7408580A
NL7408580A NL7408580A NL7408580A NL7408580A NL 7408580 A NL7408580 A NL 7408580A NL 7408580 A NL7408580 A NL 7408580A NL 7408580 A NL7408580 A NL 7408580A NL 7408580 A NL7408580 A NL 7408580A
Authority
NL
Netherlands
Prior art keywords
esp
prepns
powder
carrier
contg
Prior art date
Application number
NL7408580A
Other languages
Dutch (nl)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Priority to NL7408580A priority Critical patent/NL7408580A/en
Publication of NL7408580A publication Critical patent/NL7408580A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Powder prepns. for treating burns comprise (a) silver sulphadiazine (I) and (b) a carrier which swells spontaneously on contact with the fluid from the wound at ambient temp. The powder can be applied without touching the wound, whereupon it rapidly forms an ointment-like mass, which can be removed simply by immersion in or spraying with water. The prepns. can be sterilised (cf. prior art ointments). The carrier pref. makes up 97-99.7% of the wt. of the prepn. It pref. comprises 5-99.7 (esp. 5-90) wt% of a swelling agent (e.g. an Al silicate, a Mg-Al silicate, Na alginate, pectin or CMC), 0-94 (esp. 50-94) wt% of a filler (e.g. microcrystalline cellulose, non-swellable starch, MgCO3 or CaCO3), 0-5 (esp. 0.5-5) wt% of a lubricant (e.g. SiO2, Mg stearate, MgO or a higher fatty acid glyceride), and 0-1 (esp. 0.1-1) wt% of a wetting agent (e.g. Na lauryl sulphate, dioctyl Na sulphosuccinate or polyoxyethylene-sorbitan monooleate).
NL7408580A 1974-06-26 1974-06-26 Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier NL7408580A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7408580A NL7408580A (en) 1974-06-26 1974-06-26 Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7408580A NL7408580A (en) 1974-06-26 1974-06-26 Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier

Publications (1)

Publication Number Publication Date
NL7408580A true NL7408580A (en) 1975-12-30

Family

ID=19821620

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7408580A NL7408580A (en) 1974-06-26 1974-06-26 Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier

Country Status (1)

Country Link
NL (1) NL7408580A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424740A1 (en) * 1978-02-06 1979-11-30 Fresenius Chem Pharm Ind Finely divided metal sulpha-diazine salts - useful as antibacterials in ointments, lotions, etc. for human or veterinary use
EP0326145A1 (en) * 1988-01-29 1989-08-02 Konrad Minninger Agent containing silver sulphadiazine for local external therapy
EP0361722A2 (en) * 1988-09-12 1990-04-04 JOHNSON & JOHNSON MEDICAL, INC. (a New Jersey corp.) Antibacterial adhesive composition
EP0529396A1 (en) * 1991-08-22 1993-03-03 Beiersdorf Aktiengesellschaft Galenic matrix
WO1997033632A2 (en) * 1996-03-13 1997-09-18 Giltech Limited Alginate containing antimicrobial composition

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424740A1 (en) * 1978-02-06 1979-11-30 Fresenius Chem Pharm Ind Finely divided metal sulpha-diazine salts - useful as antibacterials in ointments, lotions, etc. for human or veterinary use
EP0326145A1 (en) * 1988-01-29 1989-08-02 Konrad Minninger Agent containing silver sulphadiazine for local external therapy
WO1989006962A1 (en) * 1988-01-29 1989-08-10 Konrad Minninger Silver sulfadiazine-containing agent for topical external therapy
EP0361722A2 (en) * 1988-09-12 1990-04-04 JOHNSON & JOHNSON MEDICAL, INC. (a New Jersey corp.) Antibacterial adhesive composition
EP0361722A3 (en) * 1988-09-12 1990-08-01 Johnson & Johnson Patient Care, Inc. Antibacterial adhesive composition
EP0529396A1 (en) * 1991-08-22 1993-03-03 Beiersdorf Aktiengesellschaft Galenic matrix
WO1997033632A2 (en) * 1996-03-13 1997-09-18 Giltech Limited Alginate containing antimicrobial composition
WO1997033632A3 (en) * 1996-03-13 1997-10-23 Giltech Ltd Alginate containing antimicrobial composition

Similar Documents

Publication Publication Date Title
WO2003000155A3 (en) Compositions and methods for reducing blood and fluid loss from open wounds
GB1496751A (en) Moisture-expandable wick
AU567968B2 (en) Device for controlled release of active ingredients
GB1550010A (en) Surgical prosthetic device or implant having pure metal porous coating
AR003684A1 (en) MULTILAYER BIOCIDAL COMPOSITION INTENDED TO PROVIDE THE SUSTAINED RELEASE OF CHLORINE DIOXIDE.
NO901229L (en) WATER-INSOLABLE DERIVATIVES OF HYALURONIC ACID.
FI820467L (en) PHARMACEUTICAL COMPOSITION SOM FRIGOERS KONTINUERLIGT
PH31652A (en) Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue.
KR940005290A (en) Bioadhesive Therapeutic Compositions and Methods of Use
AR224716A1 (en) PROCEDURE FOR THE DECOUNTRY OF AQUEOUS SYSTEMS AND HUMIDIFYING AGENT AND FOAM REPRESSOR TO TAKE SUCH PROCEDURE INTO PRACTICE
NL7408580A (en) Powder prepns for burn treatment - contg silver sulfadiazine and a swellable carrier
JPS52139715A (en) Coated granules of alkali polyacrylate
BR9814240A (en) Process for the production of low density gel compositions
ES2180649T3 (en) ANTI-ADHERENT AGENT.
MX168426B (en) METHOD FOR MANUFACTURING A MEDICAL DEVICE AND THE MANUFACTURED MEDICAL DEVICE
BRPI0417585A (en) pregabalin composition
ES2180774T3 (en) THE USE OF GLYCERYL TRIACETATE FOR THE TREATMENT OF ONYCOMYCOSIS.
NL7810763A (en) AUTOMATIC EMERGENCY STOP DEVICE AGAINST BACKFLOW AND BURN-BACK OF GAS MASSES.
GB2009597A (en) Gelled Antacid Dosage Units
KR830008166A (en) Shelf life indicator of product releasing active agent into air
NO934672L (en) Device suitable for intrauterine use
AR002424A1 (en) A BUFFER APPLICATOR CONTAINING A WATER-SOLUBLE COATING, APPARATUS AND METHOD FOR MANUFACTURING IT.
JPS52114487A (en) Oxygen absorbent and use thereof
NL7015810A (en) Biocidal and/or deodorising compsns contgcarrageenans as ge
FR2342304A1 (en) Polysaccharide derivs absorbable by body tissue - made by treating a substd polysaccharide in acid or alkaline medium and heating to give a reducing capacity of at least 15